MITCHELL WEIKERT to Antiretroviral Therapy, Highly Active
This is a "connection" page, showing publications MITCHELL WEIKERT has written about Antiretroviral Therapy, Highly Active.
Connection Strength
0.826
-
Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology. 2013 Jun; 120(6):1262-70.
Score: 0.175
-
Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2012 Jun; 153(6):1016-24.e5.
Score: 0.162
-
Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis. Am J Ophthalmol. 2011 Oct; 152(4):628-637.e1.
Score: 0.156
-
Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors. Clin Infect Dis. 2010 Oct 15; 51(8):947-56.
Score: 0.148
-
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes. Ophthalmology. 2010 Nov; 117(11):2152-61.e1-2.
Score: 0.146
-
Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus. Am J Ophthalmol. 2011 Jun; 151(6):999-1006.e4.
Score: 0.038